Trial reportJournal of the American Society of Hypertension : JASH2016
Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.
Trial report in Journal of the American Society of Hypertension : JASH, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 3 syntheses or guidelines pooled it.
- Pharmacist-integrated collaborative outpatient care for risk factor control across the cardiovascular-kidney-metabolic spectrum: a systematic review and meta-analysis of randomized trials.Frontiers in medicine · 2026Pooled it
- Can integrated care interventions strengthen primary care and improve outcomes for patients with chronic diseases? A systematic review and meta-analysis.Health research policy and systems · 2025Pooled it
- Involving community pharmacists in interprofessional collaboration in primary care: a systematic review.BMC primary care · 2024Pooled it
- The role of clinical pharmacist in the management of resistant hypertension.Irish journal of medical science · 2025Trial
- Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.Circulation. Cardiovascular quality and outcomes · 2018Trial
- Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.Pharmacotherapy · 2018Trial
- Physician-Pharmacist Collaborative Management: Narrowing the Socioeconomic Blood Pressure Gap.Hypertension (Dallas, Tex. : 1979) · 2016Trial
- Task sharing in an interprofessional medication management program - a survey of general practitioners and community pharmacists.BMC health services research · 2022Article
- Expansion of Pharmacy Services During COVID-19: Pharmacists and Pharmacy Extenders Filling the Gaps Through Telehealth Services.Hospital pharmacy · 2022Article
- Opportunity for Pharmacists in Telehealth, Team-Based Care: Clinical Inertia.Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2020Article
- Evaluation of a clinical pharmacist team-based telehealth intervention in a rural clinic setting: a pilot study of feasibility, organizational perceptions, and return on investment.Pilot and feasibility studies · 2020Article
- The Utilization of Complementary and Alternative Medicine among Saudi Older Adults: A Population-Based Study.Evidence-based complementary and alternative medicine : eCAM · 2020Article
- Consultant Pharmacist⁻Provider Collaboration in U.S. Assisted Living Facilities: A Pilot Study.Pharmacy (Basel, Switzerland) · 2019Article
- Collaborative care model for hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2018Article
- Trajectory of systolic blood pressure in a low-income, racial-ethnic minority cohort with diabetes and baseline uncontrolled hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Team-based care has been recommended for patients with treatment-resistant hypertension (TRH), but its efficacy in this setting is unknown. We compared a physician-pharmacist collaborative model (PPCM) to usual care in patients with TRH participating in the Collaboration Among Pharmacists and Physicians To Improve Outcomes Now study. At baseline, 169 patients (27% of Collaboration Among Pharmacists and Physicians To Improve Outcomes Now patients) had TRH: 111 received the PPCM intervention and 58 received usual care. Baseline characteristics were similar between treatment arms. After 9 months, adjusted mean systolic blood pressure was reduced by 7 mm Hg more with PPCM intervention than usual care (P = .036). Blood pressure control was 34.2% with PPCM versus 25.9% with usual care (adjusted odds ratio, 1.92; 95% confidence interval, 0.33-11.2). These findings suggest that team-based care in the primary care setting may be effective for TRH. Additional research is needed regarding the long-term impact of these models and to identify patients most likely to benefit from team-based interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.